Consensus or Controversy? The Integration of Novel Therapies into the Interdisciplinary Management of Non-Small Cell Lung Cancer with CNS Metastases

November 23, 2019, Phoenix, Arizona

A Satellite Symposium During the 24th Annual Meeting and Education Day of the Society for Neuro-Oncology

Please note that slides are for review only and not to be repurposed or published.

MODULE 1:
Prevalence and Clinical Significance of Central Nervous System (CNS) Involvement in Non-Small Cell Lung Cancer (NSCLC); Indications for Various Local Treatment Modalities — Dr Gomez

MODULE 2:
Optimal Management of Brain Metastases in Oncogene-Driven NSCLC — Dr Riely

MODULE 3:
Management of Leptomeningeal Metastases (LM) in NSCLC with a Targetable Tumor Mutation; Role of Immune Checkpoint Inhibition in the Treatment of CNS Disease Stemming from NSCLC — Dr Ahluwalia